Showing results (191-200 of 243) with videos related to
Sort By:
Pageof 25
International Journal of Clinical Oncology|July 29, 2019
Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II studyAya Fukuizumi, Yuji Minegishi, Miwako Omori, et al.Experimental Cell Research|December 11, 2020
Rictor-targeting exosomal microRNA-16 ameliorates lung fibrosis by inhibiting the mTORC2-SPARC axisMinoru Inomata, Koichiro Kamio, Arata Azuma, et al.British Journal of Cancer|November 27, 2020
Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846Teppei Sugano, Mari Masuda, Fumitaka Takeshita, et al.ESMO Open|March 6, 2018
Oral rehydration solution (OS-1) as a substitute of intravenous hydration after cisplatin administration in patients with lung cancer: a prospective multicenter trialHidehito Horinouchi, Kaoru Kubota, Akihiko Miyanaga, et al.Genes, Chromosomes & Cancer|April 16, 2003
Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancerAkinobu Yoshimura, Akihiko Gemma, Yoko Hosoya, et al.Lung Cancer (Amsterdam, Netherlands)|February 10, 2022
Deciphering the clinical features of heterogeneous stage III non-small cell lung cancer in Japanese real-world clinical practice: Expanded cohort of the SOLUTION studyHaruyasu Murakami, Hidehito Horinouchi, Hideyuki Harada, et al.Oncotargets and Therapy|October 2, 2018
A case of interstitial lung disease with alveolar hemorrhage induced by pembrolizumabTeppei Sugano, Masahiro Seike, Rintaro Noro, et al.Molecular and Clinical Oncology|March 7, 2022
Carboplatin plus nanoparticle albumin-bound paclitaxel for the treatment of thymic carcinomaAkiko Takahashi, Rintaro Noro, Natsuki Takano, et al.Experimental and Therapeutic Medicine|November 9, 2012
Anticancer drug clustering based on proteomic profiles and a sensitivity database in a lung cancer cell line panelMitsunori Hino, Kuniko Matsuda, Akihiko Miyanaga, et al.JTO Clinical and Research Reports|April 22, 2024
Phosphoproteomic Analysis Identified Mutual Phosphorylation of FAK and Src as a Mechanism of Osimertinib Resistance in EGFR-Mutant Lung CancerTakehiro Tozuka, Rintaro Noro, Keisuke Yoshida, et al.Pageof 25